About this event

  • Date and time Fri 14 Oct 2022 from 8:30am to 4:30pm
  • Location Royal Society of Medicine
  • Organised by Urology

Attend this event to examine the journey of cancer patients, through treatment and into survivorship, by hearing from both patients and medical professionals. 

Leading experts will lecture on management strategies for urological side effects that may result from cancer treatment and complications, such as sexual dysfunction, chronic pain and urinary problems.

We will also take time to consider the psychology of survivorship and how the medical profession can help patients navigate this journey. 

Aims of this lecture include:

  • To understand the impact of cancer and its treatment on patients. 
  • To understand the concept of survivorship.
  • To recognize the symptoms and complications of cancer and its treatment.
  • To improve understanding on how complications can be managed. 

 

Book to attend this event in person or virtuallyTo view the rates and agenda, please select your preference below.  

Follow us on: 

Facebook 
Instagram 
LinkedIn 
Twitter 
YouTube 

Show Virtual / In Person rates

Tickets (In Person)

Early bird pricing available until 31 August 2022.

Member

RSM Fellow RSM Associate RSM Retired Fellow RSM Student RSM Trainee
£77.00 £46.00 £46.00 £24.00 £0.00

Non - Member

Consultant / GP / SAS Doctors AHP / Nurse / Midwife Student Trainee
£141.00 £84.00 £44.00 £0.00

Tickets (Virtual)

Early bird pricing available until 31 August 2022.

Member

RSM Fellow RSM Associate RSM Retired Fellow RSM Trainee RSM Student
£72.00 £43.00 £43.00 £43.00 £23.00

Non - Member

Consultant / GP / SAS Doctors AHP / Nurse / Midwife Trainee Student
£132.00 £79.00 £79.00 £41.00

Key speakers

Mrs Renee Holmes

Chair, Mitrofanoff Support

Sarah Psutka

Dr Sarah Psutka

Associate Professor of Urology, University of Washington

Speaker's biography

Dr Sarah Psutka MD, MSc is an Associate Professor of Urology in the Department of Urology at the University of Washington and Fred Hutchinson Cancer Center. She received her undergraduate and medical degrees from Harvard University and completed urology residency training at the Massachusetts General Hospital. She completed a Society of Urologic Oncology Fellowship in Urologic Oncology at the Mayo Clinic, and concurrently obtained her Masters’ in Clinical and Translational Science.

 

Dr Psutka’s clinical efforts focus on minimally-invasive and complex open urologic oncology, with a particular interest in advanced bladder, kidney, and testis cancer. She leads the urologic oncology program at Harborview Medical Center and is the Associate Program Director of the UW Society of Urologic Oncology Fellowship Program.

 

Dr Psutka’s research focuses on the study and development of personalized, comprehensive risk stratification measures in patients with advanced urologic malignancies. She leads research studying the integration of principles of aging research, comprehensive geriatric assessments, body composition, and psychometric capital assessments in patients with advanced genitourinary malignancies with a focus on patient-reported outcomes and development of prehabilitation interventions. She currently leads multiple clinical trials in bladder and kidney cancer. Her research has been funded by the Bladder Cancer Advocacy Network and she was the 2022 Recipient of the Society of Urologic Oncology Young Investigator Award. She is a member of the Board of Directors of the Society of Urologic Oncology, the Society of Urologic Oncology Clinical Trials Consortium (Kidney), The Society of Urologic Oncology Fellowship Committee and Education Committee, the SWOG Clinical Trials Survivorship Committee, and the Bladder Cancer Advocacy Network Steering Committee. She was a co-founder of the Society of Women in Urologic Oncology.

 

Dr Psutka is the Senior Editor for the Urologic Oncology Section of the American Urological Association Core Curriculum and is an Associate Editor for European Urology.

Dr Clare Allen

Consultant Radiologist, University College London Hospitals NHS Trust

Professor Maarten Albersen

Professor of Urology, University Hospitals Leuven

Agenda

View the programme (In person)

Registration, tea and coffee

Morning session

Welcome and introduction

Ms Nadine Coull, President, Urology Section, Royal Society of Medicine

But you’re cured, so you’re fine

Mrs Renee Holmes, Chair, Mitrofanoff Support

 

What is survivorship?

Mr Derek Rosario, Urologist, Sheffield Teaching Hospitals NHS Foundation Trust

The psychology of survivorship

Dr Sahil Suleman, Macmillan Consultant Clinical Psychologist, St George's University Hospitals NHS Foundation Trust

Sexual dysfunction following treatment for cancer

Miss Lorraine Grover, Psychosexual Nurse Specialist, The Prostate Centre

Questions and answers
Tea and coffee break
Tools for measurement in in survivorship

Dr Sarah Psutka, Associate Professor of Urology, University of Washington

Managing chronic pain after cancer treatment

Dr Richard Gordon, Hematologist-Oncologist, Comprehensive Cancer and Hematology Specialists

Long-term complications of radiotherapy for urological cancers

Mr Arun Sahai, Consultant Urological Surgeon, Guy's and St Thomas' NHS Foundation Trust

Questions and answers
Lunch

Afternoon Session: When things go wrong

Imaging the problem

Dr Clare Allen, Consultant Radiologist, University College London Hospitals NHS Trust

Post treatment fistulae - a ticking time bomb

Miss Tamsin Greenwell, Consultant Urological Surgeon, University College London Hospitals and Honorary Associate Professor, University College London

Post treatment strictures

Professor Anthony Mundy, Professor of Urology and Consultant Urological Surgeon, University College London Hospitals

Post treatment urinary symptoms

Mr Mark Speakman, Consultant Urologist, Taunton and Somerset NHS Foundation Trust

Post treatment erectile dysfunction

Professor Maarten Albersen, Professor of Urology, University Hospitals Leuven

Questions and answers
State of the art lecture: Current Management of penile cancer

Professor Maarten Albersen

Closing remarks

Ms Nadine Coull

Close of meeting
View the programme (Virtual)

Morning session

Welcome and introduction

Ms Nadine Coull, President, Urology Section, Royal Society of Medicine

But you’re cured, so you’re fine

Mrs Renee Holmes, Chair, Mitrofanoff Support

What is survivorship?

Mr Derek Rosario, Urologist, Sheffield Teaching Hospitals NHS Foundation Trust

The psychology of survivorship

Dr Sahil Suleman, Macmillan Consultant Clinical Psychologist, St George's University Hospitals NHS Foundation Trust

Sexual dysfunction following treatment for cancer

Miss Lorraine Grover, Psychosexual Nurse Specialist, The Prostate Centre

Questions and answers
Comfort break
Tools for measurement in in survivorship

Dr Sarah Psutka, Associate Professor of Urology, University of Washington

Managing chronic pain after cancer treatment

Dr Richard Gordon, Hematologist-Oncologist, Comprehensive Cancer and Hematology Specialists

Long-term complications of radiotherapy for urological cancers

Mr Arun Sahai, Consultant Urological Surgeon, Guy's and St Thomas' NHS Foundation Trust

Questions and answers
Comfort break

Afternoon session: When things go wrong

Imaging the problem

Dr Clare Allen, Consultant Radiologist, University College London Hospitals NHS Trust

Post treatment fistulae - a ticking time bomb

Miss Tamsin Greenwell, Consultant Urological Surgeon, University College London Hospitals and Honorary Associate Professor, University College London

Post treatment strictures

Professor Anthony Mundy, Professor of Urology and Consultant Urological Surgeon, University College London Hospitals

Post treatment urinary symptoms

Mr Mark Speakman, Consultant Urologist, Taunton and Somerset NHS Foundation Trust

Post treatment erectile dysfunction

Professor Maarten Albersen, Professor of Urology, University Hospitals Leuven

Questions and answers
State of the art lecture: Current Management of penile cancer

Professor Maarten Albersen

Closing remarks

Ms Nadine Coull

Close of meeting

Location

Royal Society of Medicine, 1 Wimpole St, Marylebone, London, W1G 0AE, United Kingdom

Registration for this event will close at 1:00am on 13 October 2022. Late registrations will not be accepted.  

The agenda is subject to change at any time 

If the event is recorded, we are only able to share presentations that we have received permission to share. There is no guarantee that all sessions will be available after the event, this is at the presenters and RSM discretion. 

All views expressed at this event are of the speakers themselves and not of the Royal Society of Medicine, nor the speaker's organisations. 

This event will be recorded and stored by the Royal Society of Medicine and may be distributed in future on various internet channels.